600671 天目藥業
按盤價 
19.230 +0.320 (+1.692%) | 2026/06 - 中期 | 2025/12 | 2024/12 | 2023/12 | 2022/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 8.615 | 28.797 | 34.061 | -339.450 | -441.328 |
| 總資產報酬率 ROA (%) | 1.410 | 3.989 | 3.871 | -11.798 | -19.148 |
| 投入資產回報率 ROIC (%) | 2.342 | 7.440 | 8.055 | -28.512 | -49.337 | 邊際利潤分析 |
| 銷售毛利率 (%) | 50.379 | 47.763 | 47.380 | 21.787 | 22.934 |
| 營業利潤率 (%) | 4.565 | 3.963 | 11.557 | -30.851 | -64.168 |
| 息稅前利潤/營業總收入 (%) | 11.722 | 8.176 | 15.771 | -23.961 | -59.650 |
| 淨利潤/營業總收入 (%) | 4.973 | 3.402 | 10.062 | -32.268 | -67.143 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 75.689 | 94.273 | 97.726 | 81.953 | 50.760 |
| 價值變動淨收益/利潤總額(%) | -0.067 | 16.711 | 0.099 | 1.448 | -1.333 |
| 營業外收支淨額/利潤總額(%) | 45.251 | 17.915 | 13.618 | -3.468 | 3.431 | 償債能力分析 |
| 流動比率 (X) | 0.840 | 0.809 | 0.778 | 0.824 | 0.561 |
| 速動比率 (X) | 0.707 | 0.670 | 0.595 | 0.629 | 0.346 |
| 資產負債率 (%) | 78.116 | 78.736 | 80.742 | 83.843 | 98.493 |
| 帶息債務/全部投入資本 (%) | 50.860 | 46.729 | 44.117 | 32.814 | 42.978 |
| 股東權益/帶息債務 (%) | 52.897 | 58.844 | 54.190 | 70.998 | -31.116 |
| 股東權益/負債合計 (%) | 21.609 | 20.115 | 14.696 | 12.791 | -4.895 |
| 利息保障倍數 (X) | 3.464 | 2.442 | 6.594 | -4.092 | -8.776 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 237.052 | 204.353 | 110.378 | 99.756 | 135.909 |
| 存貨周轉天數 (天) | 142.010 | 148.910 | 149.976 | 171.044 | 214.290 |
| 備註： | 即時報價更新時間為 22/10/2026 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
